|
Originally published In Press as doi:10.1074/jbc.M106883200 on October 17, 2001
J. Biol. Chem., Vol. 277, Issue 1, 135-140, January 4, 2002
The Capsid Protein of a Plant Single-stranded RNA Virus Is
Modified by O-Linked N-Acetylglucosamine*
M. Rosario
Fernández-Fernández ,
Emilio
Camafeita ,
Pedro
Bonay§,
Enrique
Méndez ,
Juan Pablo
Albar , and
Juan A.
García ¶
From the Centro Nacional de Biotecnología,
Consejo Superior de Investigaciones Científicas, and
§ Centro de Biología Molecular "Severo Ochoa,"
Campus de la Universidad Autónoma de Madrid, 28049 Cantoblanco,
Madrid, Spain
Received for publication, July 20, 2001, and in revised form, October 16, 2001
 |
ABSTRACT |
Plum pox virus (PPV) is a member of the
Potyvirus genus of plant viruses. Labeling with
UDP-[3H]galactose and galactosyltransferase indicated
that the capsid protein (CP) of PPV is a glycoprotein with
N-acetylglucosamine terminal residues. Mass spectrometry
analysis of different PPV isolates and mutants revealed
O-linked N-acetylglucosamination, a
modification barely studied in plant proteins, of serine and/or threonine residues near the amino end of PPV CP. CP of PPV virions is
also modified by serine and threonine phosphorylation, as shown by
Western blot analysis with anti-phosphoserine and anti-phosphothreonine antibodies. Thus, "yin-yang" glycosylation and phosphorylation may
play an important role in the regulation of the different functions in
which the potyviral CP is involved.
 |
INTRODUCTION |
O-Linked N-acetylglucosamine (O-GlcNAc) is a
simple monosaccharide modification that is abundant on serine or
threonine residues of nuclear and cytoplasmic eukaryotic proteins (1,
2). Although many proteins of animal origin have been found to carry
this modification, including transcription factors, cytoskeletal
proteins, nuclear pore proteins, viral proteins, oncogene products, and
tumor suppressors, very little is known about its incidence in the
plant world (3). O-GlcNAc has been suggested to be
reciprocal to phosphorylation (2), and some studies carried out on
different proteins have shown that O-GlcNAc and
O-phosphate alternatively occupy the same or adjacent sites.
This supports the hypothesis that the saccharide could somehow be
blocking phosphorylation (4).
Structural proteins from several animal viruses such as the
cytomegalovirus basic phosphoprotein (5), the adenovirus fiber protein
(6), and the baculovirus gp41 protein (7), as well as the
non-structural NS26 protein from a rotavirus (8), have been described
to be modified by O-GlcNAc, but no function for these
modifications has been envisaged.
Plum pox virus (PPV)1 is a
member of the Potyvirus genus of plant viruses. PPV is the
causal agent of sharka, a very devastating disease affecting stone
fruit crops of the Prunus genus. The potyvirus genome
consists of a single-stranded messenger-polarity RNA molecule of about
10 kb, with a VPg protein at its 5' end and a poly(A) tail at its 3'
end. This genome is translated into a large polyprotein that is further
processed by three virus-encoded proteases (9, 10). The genome is
encapsidated by ~2000 units of a single type of capsid protein (CP),
encoded at the 3' end of the genome (11) (Fig.
1).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Sequence comparison of the N-terminal amino
acids of several PPV isolates and mutants. Foreign sequences
included in the chimeric viruses are in bold letters, and
dashes indicate the amino acids deleted by the NAT mutation.
Schematic representations of the potyvirus genome and of the three
regions of the potyvirus CP are shown above the sequences.
|
|
The potyvirus CP is involved in cell to cell and long distance movement
inside the plant. In particular, the N- and C-terminal parts of the CP
are known to be involved in systemic movement (12, 13). Moreover, the
N-terminal region of the potyvirus CP, which is extremely variable
among different virus species, holds an Asp-Ala-Gly (DAG) amino acid
triad that is essential for aphid transmission (14, 15).
The CP from a potyvirus, the potato virus A (PVA), has been described
recently to be phosphorylated in serine and threonine residues (16),
and this modification appears to down-regulate the RNA binding function
of PVA CP. In this paper we explain that PPV CP, in addition to being
phosphorylated, is modified by O-linked N-acetylglucosamination. At least one of the glycosylated
residues lies at the N-terminal region of the protein, namely at a
15-amino acid sequence that is deleted in some natural
non-aphid-transmissible (NAT) PPV mutants (17, 18). To our knowledge
this is the first extensive characterization of this modification in a
plant protein.
 |
EXPERIMENTAL PROCEDURES |
Virus Infection and Purification--
PPV strains R and PS and
the chimeras PPV-CPV (19) and PPV-MCMV (20) were used in these
experiments. Viruses were propagated in Nicotiana
clevelandii plants. To establish systemic infection, young plants
were mechanically inoculated by rubbing three leaves per plant with
crude sap from PPV-infected leaves (1 g of leaf tissue in 2 ml of 5 mM sodium phosphate, pH 7.2), using Carborundum as an
abrasive. The virus was purified according to Laín et
al. (21).
Galactosyltransferase Assay--
Eight µg of purified PPV
virions were labeled in a 100-µl reaction mixture with uridine
diphospho[6-3H]galactose (UDP-galactose) (5-20 Ci/mmol)
(Amersham Biosciences, Inc.) and bovine milk
galactosyltransferase (galactosyltransferase) (Sigma) according to the
method described by Roquemore et al. (2). As positive and
negative controls, a protein mixture containing 10 µg of
chymotrypsinogen A, ovalbumin, serum albumin, and aldolase (Roche
Molecular Biochemicals) was labeled in the same conditions. UDP-galactose labeling of galactosyltransferase in the absence of other
added proteins was also carried out as an additional control. After the
labeling reaction the samples were loaded in a Sephadex G-50 column to
separate labeled proteins from unincorporated UDP-galactose.
PPV CP was immunoprecipitated with a mixture of protein A-Sepharose
(Sigma) and polyclonal serum against PPV (or a control preimmune serum)
in a buffer containing 150 mM NaCl, 10 mM
Tris-HCl, pH 7.8, 1% Triton X-100, and 0.1% SDS.
Labeled products (before or after immunoprecipitation) were separated
in a 12.5% SDS-polyacrylamide gel and detected by fluorography, after
treatment of the gel with Amplify (Amersham Biosciences, Inc.).
Western Blot Analysis--
Two different amounts of purified
virions of wild-type PPV-R and PPV-PS and chimeric PPV-CPV in addition
to a negative control, bovine serum albumin (Roche Molecular
Biochemicals), were separated by SDS-PAGE in triplicate. One gel was
stained with Coomassie Blue, and the two other ones were transferred to
nitrocellulose membranes. The membranes were saturated with 2% bovine
serum albumin and subjected to immunodetection. Two different
monoclonal antibodies, anti-phosphoserine and anti-phosphothreonine
(Calbiochem), were used as primary antibodies at a concentration of 0.1 µg/ml. The secondary antibody was a peroxidase-conjugated goat
anti-mouse purchased from Jackson ImmunoResearch Laboratories (1:1500).
The peroxidase reaction was developed with the ECLTM kit
(Amersham Biosciences, Inc.).
Matrix-assisted Laser Desorption/Ionization-Time of Flight
(MALDI-TOF) Analysis of PPV CP Digested with Proteases--
Ten µg
of purified PPV-R, PPV-CPV, and PPV-MCMV virions were digested for
5-15 min at room temperature with 1.7 ng of trypsin (Promega) in a
buffer containing 25 mM Tris-HCl, pH 8, and 1 mM EDTA in a reaction volume of 10 µl. Alternatively, 10 µg of purified virions were first digested for 5 h at room
temperature with 1 µg of protease V8 (Sigma) in 10 µl of 10 mM pH 8, then 5 ng of trypsin were added to 5 µl of the
digestion mixture, and the reaction was left at room temperature for 30 min.
For MALDI-TOF analysis 0.5-µl aliquots of the reaction mixtures were
deposited onto the stainless steel MALDI probe and allowed to dry at
room temperature. Then 0.5 µl of matrix solution (saturated -cyano-4-hydroxycinnamic acid in 33% aqueous acetonitrile and 0.1%
trifluoroacetic acid) were added and again allowed to dry at room
temperature. The spectra were acquired in a MALDI-TOF Bruker ReflexTM
II equipped with visualization optics and a nitrogen laser (337 nm).
Linear mode was used, with an acceleration voltage of 28.5 and 1.5 kV
in the linear detector, accumulating 100 spectra corresponding to the
same number of laser shots in conditions of threshold irradiance. The
spectrometer was externally calibrated using the singly and doubly
charged signals from bovine insulin.
The post-source decay (PSD) MALDI spectra were measured on a Bruker
ReflexTM III MALDI-TOF mass spectrometer equipped with the SCOUTTM
source in positive ion reflector mode using delayed extraction (22).
Spectra were recorded in 14 segments, each successive segment
representing a 20% reduction in reflector voltage. The precursor ion
was selected by FASTTM deflecting pulses. About 200 shots
were averaged per segment, and the segments were pasted, calibrated,
and smoothed under the computer control of Bruker XTOF 5.0.3 software.
Data analysis was performed using Bruker BioTools 2.0 software.
 |
RESULTS |
PPV Virions Are Labeled by Galactosyltransferase--
A common and
sensitive method frequently used in the detection of
O-linked N-acetylglucosamination of proteins is
to covalently label the protein-bound sugar with
UDP-[3H]galactose and galactosyltransferase (2). Thus, to
gain a first insight into the possibility that the PPV CP could be
modified by O-GlcNAc residues, PPV-R virions purified from
N. clevelandii plants were subjected to that treatment. Two
different lots of purified virions were treated in order to ensure that
the results are representative of the general PPV population rather
than specific features of a batch of purified virions. The fluorography
of the reaction products, separated by SDS-PAGE, revealed the presence of proteins labeled with [3H]galactose in the PPV
samples, with a main band having the electrophoretic mobility expected
for PPV-R CP (Fig. 2, lanes 1 and 2). Ovalbumin, a well known glycoprotein, was strongly
labeled, whereas other proteins included in the control reactions
remained unlabeled (Fig. 2, lane 3). Although it was not
detected in the fluorography shown in Fig. 2 (lane 4),
measurement by liquid scintillation of the incorporated radioactivity
demonstrated a weak autolabeling of the galactosyltransferase (data not
shown).

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 2.
[3H]Galactose labeling of
PPV-purified virions. Two different batches of purified PPV
virions (lanes 1, 5, and 6 and
lanes 2, 7, and 8) were enzymatically
labeled with galactosyltransferase and UDP-[3H]galactose.
A mixture of marker proteins containing chymotrypsinogen A, ovalbumin,
serum albumin, and aldolase (lanes 3 and 9) was
also subjected to the labeling reaction. The reaction products were
loaded on the gel and subjected to SDS-PAGE directly (lanes
1-4) or after immunoprecipitation (6 times the amount directly
loaded) with anti-PPV (lanes 6, 8, 9,
and 10) or preimmune (lanes 5 and 7)
sera. Total (lane 4) or immunoprecipitated with anti-PPV
serum (lane 10) products of a labeling reaction lacking
substrate were also analyzed. The gel was treated with Amplify
(Amersham Biosciences, Inc.) and autoradiographed. The sizes of
prestained broad range molecular weight markers (Bio-Rad) run in the
lane labeled Mr are indicated at the left side of
the panel.
|
|
The [3H]galactose labeling of PPV-CP by the
galactosyltransferase treatment was confirmed by immunoprecipitation. A
protein with the size expected for PPV-R CP was immunoprecipitated by a
polyclonal antibody against PPV from the products of the labeling reactions of PPV virions (Fig. 2, lanes 6 and 8).
No labeled bands were detected when these samples were
immunoprecipitated with a preimmune serum (Fig. 2, lanes 5 and 7) or when the labeled products of the control reactions
were immunoprecipitated with the anti-PPV serum (Fig. 2, lanes
9 and 10).
MALDI-TOF Analysis Suggests That the N-terminal Region of PPV-CP Is
Modified with O-GlcNAc Residues--
The labeling of PPV-CP with
galactosyltransferase demonstrates that this protein is modified with
sugars that have terminal residues of N-acetylglucosamine,
but it gives no indication of the nature of the saccharide architecture
linked to the polypeptide bond. To obtain more information about the
sugars linked to PPV-CP, purified virions of the PPV-R isolate were
subjected to a mild trypsin digestion, and the resulting peptides were
analyzed by MALDI-TOF (Fig. 3). This
protease treatment is expected to mainly affect the N- and C-terminal
regions of the protein, which are known to be exposed at the surface of
the virions. In agreement with this, a peptide was detected with the
size (4075 Da) of a tryptic peptide spanning amino acids 1 to 39 of the
CP of PPV-R (no cleavage appears to take place efficiently at arginine
4). Two other major peptide mass signals appeared in the spectrum at
m/z = 4278 and 4481. These two peptides
differ from the 4075 peptide in 203 and 406 Da, as expected for a
single and double modification with O-GlcNAc. The assumption
that the 4278 and 4881 peptides are variants of the 4075 peptide linked
to one or two residues of O-GlcNAc was further supported by
the fact that the three main peaks were accompanied by small satellite
peaks 42 Da apart. The three minor peptides could be the result of
N-acetylation of the unmodified and the glycosylated forms
of the N-terminal fragment of CP, which is in accordance with the
previously reported blockade of the N-terminal ends of several PPV
proteins (23).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
MALDI-TOF analysis of PPV virions digested
with proteinases. Purified virions were digested with trypsin for
5 min (PPV-R and PPV-CPV) or 15 min (PPV-MCMV) (panel A) or
with V8 for 5 h and trypsin for 30 min (panel B) and
subjected to MALDI-TOF analysis. The mass (in daltons) assigned to the
different peaks is indicated above them. The N-terminal region of each
virion CP is shown using the amino acid one-letter code. Sequences
deleted by the NAT mutation and replaced by foreign sequences in
PPV-CPV and PPV-MCMV are underlined. The arrows
indicate the position where trypsin and V8 cleave according to the
spectra results.
|
|
The 10 to 39 Sequence of PPV CP Is O-GlcNAc-modified--
Two
different approaches were followed to confirm the O-GlcNAc
modification of the N-terminal segment of PPV-CP: tryptic peptide analysis of mutated CPs and PSD analysis of the peptides presumably derived from the N-terminal region of the protein.
If the allocation of the 4075 peptide to the 1-39 amino acid sequence
was correct, this peptide could not be the target for N-glycosylation, because it does not include any asparagine
residue. On the contrary, it includes two serine and two threonine
residues, which might be the target for O-glycosylation.
PPV-CPV and PPV-MCMV are two PPV-R chimeras in which the 15 amino acids
that are deleted in the NAT PPV mutants (17, 18) are replaced by
sequences coding 15 amino acids of the VP2 protein of canine parvovirus (19) and 9 amino acids of murine cytomegalovirus pp89 phosphoprotein (20), respectively. Potential targets of trypsin digestion and O-GlcNAc modification differ in these chimeras from those of
PPV-R. Two additional arginine residues are present in the 1-39
sequence of the PPV-CPV CP, which appear to be recognized by the
trypsin treatment. Cleavage at arginine 26 gives rise to a 2910-Da
peptide, which was observed in the spectrum of Fig. 3A,
whereas the 2511-Da peptide, derived from cleavage at arginine 23, could only be detected at longer incubation times (data not shown). A
peak corresponding to a 4276-Da peptide that results from trypsin
cleavage at arginine 39 was detected at short digestion times (Fig.
3A). However, no peaks attributable to O-GlcNAc
modifications of this peptide could be detected, as expected from the
absence of serine and threonine residues in the 1-39 sequence of the
PPV-CPV CP sequence. The additional peak at
m/z = 2757 displayed in the spectrum of Fig. 3A, could be attributed to a partially digested peptide from
the C-terminal region of PPV CP and disappeared at longer incubation times (data not shown).
The MALDI-TOF spectrum of the tryptic peptides of PPV-MCMV CP revealed
the presence of a peak at the position expected for the 4341-Da peptide
resulting from trypsin cleavage at arginine 39 (Fig. 3A).
Moreover, a peak corresponding to the acetylated form of this peptide
(4383 Da) was also detected, and it was more prominent than those from
the other PPV CP samples (Fig. 3A). Despite the fact that
serine 16 of PPV CP is conserved in PPV-MCMV CP and that this chimeric
protein contains a new threonine residue, no peaks that could
correspond to peptides modified with O-GlcNAc residues were
detected in the spectrum (Fig. 3A). This result appears to
indicate that the MCMV-derived threonine 24 is not susceptible to
O-GlcNAc modification and that either serine 16 is not
glycosylated in wild-type PPV CP or its new context in PPV-MCMV CP
prevents its glycosylation.
The 1-39 peptide is too large to be suitable for an accurate MALDI-PSD
analysis. For this reason, purified PPV-R virions were subjected to
controlled double protease digestion with V8 and trypsin. V8 mainly
cleaves at the carboxylic sites of glutamic acid residues, although in
some conditions it also cleaves at aspartic acid residues. MALDI-TOF
analysis revealed the release of three peptides with masses
corresponding to a peptide of the N-terminal region of PPV-R CP
spanning amino acids 10-39 (2974 Da) and to singly (3177 Da) and
doubly (3380 Da) O-GlcNAc-modified forms of that peptide
(Fig. 3B). These three peptides were subjected to MALDI-PSD
analysis (Fig. 4 and data not shown). The
fragmentation spectrum of the smaller peptide (2974 Da) was in very
good agreement with the 10-39 sequence (83% of the expected b and y
ions could be assigned, in contrast with the 10% ion assignment
obtained for a random sequence of the same size). The spectrum of the
middle size peptide (3177 Da) conformed to the 10-39 sequence carrying a single O-GlcNAc modification. The proximity of the serine
and threonine residues precluded an accurate identification of the modified residues, although the two threonine residues appeared to be
the most likely candidates (78 and 72% of b/y ions assigned for
threonines 24 and 19, respectively). Similarly, the fragmentation spectrum of the largest peptide (3380 Da) supported its identification as the 10-39 peptide with two O-GlcNAc modifications,
although it could not ascertain whether single amino acids carried two O-GlcNAc molecules or a couple of amino acids were singly
modified and did not identify the modified residues (b/y ion
assignments among 50 and 63%).

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 4.
MALDI-PSD analysis of PPV virions. Some
of the major backbone fragmentations in linear peptides according to
Roepstorff and Folhmann (28) (panel A). PSD MALDI spectra
from peptides at m/z = 2974 (top), 3177 (middle), and 3381 (bottom). Identified "y" ions considering a +203-Da
modification located in the residues highlighted (Thr-15 for
m/z = 3177 and Thr-10 and Thr-15 for
m/z = 3381) are displayed (panel
B).
|
|
PPV CP Is Modified by Phosphorylation in Serine and Threonine
Residues--
O-GlcNAc modification appears to affect
mainly, if not exclusively, proteins that are also modified by
phosphorylation (24). In addition, phosphorylation at serine or
threonine residues has been demonstrated for the CP of the potyvirus
PVA. To assess whether PPV CP was also phosphorylated, purified virions
of different PPV isolates were subjected to Western blot analysis with
antibodies specific for phosphothreonine or phosphoserine residues. The
CPs of all three PPV isolates (PPV-PS and PPV-R, which belong to the strains M and D, respectively, and the PPV-R-derived chimeric virus
PPV-CPV) were recognized by both the anti-phosphoserine (Fig.
5B) and the
anti-phosphothreonine (Fig. 5C) antibodies. Densitometric analysis revealed that the relative intensities of the
PPV-PS anti-phosphoserine and anti-phosphothreonine immunoreactions were 2-3 times higher than those of PPV-R and PPV-CPV.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 5.
Immunodetection of PPV CP phosphorylated at
serine and threonine residues. Aliquots of ~1 µg (lanes
2, 4, 6, and 8) or 0.5 µg
(lanes 3, 5, 7, and 9) of
bovine serum albumin (lanes 2 and 3) and of
PPV-PS (lanes 4 and 5), PPV-CPV (lanes
6 and 7), and PPV-R (lanes 8 and
9) virions were loaded in three gels and subjected to 12.5%
SDS-PAGE. One gel was stained with Coomassie Blue (panel A).
The other two gels were subjected to Western blot analysis with
anti-phosphoserine (panel B) and anti-phosphothreonine
(panel C) antibodies (Calbiochem). Prestained broad range
molecular weight markers (Bio-Rad) were used as standards (lane
1).
|
|
 |
DISCUSSION |
Since the first description of protein glycosylation at specific
serine or threonine residues by single
-N-acetylglucosamine (GlcNAc) moieties (25) a large
number of cytoplasmic and nuclear proteins of many eukaryotic organisms
have been found to carry this modification (24).
O-Glycosylation with terminal GlcNAc modification has been
described for nuclear pore complex proteins of tobacco, but in contrast
with O-GlcNAc modification of animal proteins, the size of
the sugar chains of these tobacco proteins corresponded to more than
five monosaccharide units, which were not further characterized (26,
27). On the contrary, the size of one of the peptides detected by the
MALDI-TOF analysis of PPV CP corresponds to a single GlcNAc
modification (Figs. 3 and 4), resembling the typical
O-GlcNAc glycosylation of animal proteins. Taking into
account that the sequence of the PPV CP peptide carrying the identified
modification has two serine and two threonine residues, the doubly
glycosylated form detected by the MALDI-TOF analysis is likely to
correspond to two single O-GlcNAc modifications rather than
to the attachment of two O-GlcNAc molecules to a single
threonine or serine residue, although our present data do not allow us
to rule out the latter possibility. The MALDI analysis did not
precisely identify the O-GlcNAc-modified residues at the
N-terminal region of PPV CP, although the fact that no glycosylation
was detected in the 1-39 peptide of PPV-MCMV CP (Fig. 3), which
conserves Ser-16, suggests that the modification could affect residues
Thr-19, Thr-24, and/or Ser-25. In this regard, the YinOYang
program2 predicts these three
residues, but not Ser-16, as putative targets for O-GlcNAc
modification (data not shown).
O-GlcNAc modifications of structural and non-structural
proteins of animal viruses with double-stranded RNA (8) or DNA (5-7)
genomes have been described. However, to our knowledge, PPV CP is the
first protein of a plant virus and of a virus with a positive strand
RNA genome, for which a typical O-GlcNAcylation has been
unambiguously demonstrated. O-GlcNAc-modified proteins appear to have two common features: they are also phosphorylated, and
they form reversible multimeric complexes via interactions that are
regulated by phosphorylation (1). The CP of potyviruses may exhibit
both traits. Protein-protein and protein-RNA interactions have to be
established and disturbed in virion assembly and RNA desencapsidation,
respectively. Moreover, very recently it has been shown that
phosphorylation down-regulates the RNA binding activity of the CP of a
potyvirus, PVA (16). It was demonstrated that PVA CP was phosphorylated
in the infected plants, but the authors suggested that it was
not phosphorylated when packaged into virions, based on the fact that
disrupted particles but not intact virions could be phosphorylated
in vitro by a plant protein extract. Our immunoreaction
experiments (Fig. 5) appear to indicate that PPV CP was phosphorylated
at threonine and serine residues when it was assembled in virions.
These data are not in conflict with those of Ivanov et al.
(16), because phosphorylation of the assembled CP might be only
partial, and disassembled CP would, therefore, be susceptible to
further phosphorylation. In agreement with this suggestion, the
phosphorylation levels of PPV-PS and PPV-R CPs appear to be different.
Probably, these differences reflect changes in the global extent of
phosphorylation rather than specific features of the phosphorylation
patterns, because sequence analysis showed only minor differences
between PPV-PS and PPV-R CPs in the likelihood of phosphorylation at
serine and threonine residues predicted by the NetPhos 2.0 program (29) or in the total content of these amino acids (data not shown). The fact
that the CP of PPV-CPV, which lacks the two serine and two threonine
residues present in the first 39 amino acids of the CP of PPV-R, showed
a phosphorylation level similar to that of this protein suggests that
the contribution of these threonine and serine residues to the
phosphorylation status of the CP assembled in virions is rather low.
O-GlcNAcylation is known to be reciprocal to phosphorylation
in many proteins; thus, O-GlcNAc residues could be
protecting the N terminus of the CP, which is surface-exposed (30),
against phosphorylation when the CP is assembled in virions. Interestingly, six of the eight serine and threonine residues that the
YinOYang program2 predicts to be able to suffer reciprocal
O-GlcNAc/phosphate modifications are in the N-terminal
region of the PPV-R CP (data not shown). In any case, although the
simultaneous detection of O-GlcNAc modification and
phosphorylation in PPV virions could be due to the presence of a
mixture of molecules carrying each modification in an excluding manner,
it appears more likely that CP molecules forming PPV particles could be
modified with both phosphate and O-GlcNAc residues, as has
been proposed for other proteins (24).
What is the functional relevance of O-GlcNAc modifications
for PPV infection? The fact that PPV-NAT, PPV-CPV, and PPV-MCMV (Fig.
1) are viable indicates that O-GlcNAc-modified residues at
the 13-27-amino acid segment deleted by the NAT mutation are not
essential. No significant differences in infectivity or virus accumulation in herbaceous hosts have been observed between these mutant viruses and wild-type PPV under experimental conditions (data
not shown). This does not preclude the possibility that some
differences in adaptation to the selective pressure of their natural
environment could exist among these viruses. In this regard, the fact
that NAT mutants have appeared spontaneously when PPV was propagated in
herbaceous plants after transfer from its natural woody host (17, 18)
suggests that NAT region, and possibly its phosphorylation and
O-GlcNAcylation, could be important for viral fitness, at
least in some hosts. Moreover, the possibility that
O-GlcNAcylation of PPV CP is restricted to the N-terminal peptide analyzed in this work is quite unlikely, and an appropriate modification of Ser/Thr residues in other regions of the CP might be
relevant for virus viability.
An effect of protein phosphorylation on the stability of poliovirus
capsids and its consequent involvement in viral uncoating was described
some years ago (31). More recently, it has been shown that
phosphorylation of PVA CP affects its capacity to interact with RNA,
suggesting that this modification might contribute to the control of
the amount of genomic RNA available for translation, replication,
encapsidation, and movement (16). A similar role has been suggested for
the phosphorylation of the CP of PVX (32) and the movement protein of
TMV (33), which has been shown to modulate the effect of these proteins
on translation of the genomic RNA. It would be expected that
O-GlcNAcylation, reciprocal to phosphorylation, could also
play a key role in these regulatory mechanisms.
O-GlcNAc modification of the capsid protein is probably not
a specific feature of potyviruses. No data are available on this kind
of modification in animal viruses with positive strand RNA genome.
However, it has been reported that capsid proteins of some positive
strand RNA viruses of plants, namely, barley stripe virus, cowpea
mosaic virus (34), and PVX (35), could be glycosylated, although the
cowpea mosaic virus results have been recently challenged (36). The
saccharide chain appeared to be attached to the potato virus X CP via
an O-glycosidic linkage, but a more extensive
characterization of the CP sugar moieties was not done. Further work is
needed to determine the extent and the relevance of
O-GlcNAcylation and phosphorylation, as well as the
relationships between these two kinds of modifications, in the CPs of
RNA viruses.
 |
ACKNOWLEDGEMENTS |
We thank Elvira Domínguez and Juan A. López for technical assistance, Mario Mellado and José
Miguel Rodríguez-Frade from the Centro Nacional de
Biotecnología Department of Immunology and Oncology for
anti-phosphothreonine and anti-phosphoserine antibodies, and Javier
Ortego for help in immunoprecipitation experiments.
 |
FOOTNOTES |
*
This work was supported by Comisión Interministerial
de Ciencia y Tecnología, Spain Grants BIO98-0769 and
BIO2001-1434 and European Union Grant QLK2-1999-00739.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
34-1-5854535; Fax: 34-1-5854506; E-mail: jagarcia@cnb.uam.es.
Published, JBC Papers in Press, October 17, 2001, DOI 10.1074/jbc.M106883200
2
R. Gupta, S. Brunak, and J. Hansen, manuscript
in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
PPV, plum pox virus;
CP, capsid protein;
CPV, canine parvovirus;
PVA, potato virus A;
NAT, non-aphid-transmissible;
MCMV, murine cytomegalovirus;
MALDI-TOF, matrix-assisted laser desorption/ionization-time of flight;
PSD, post-source decay.
 |
REFERENCES |
| 1.
|
Hart, G. W.
(1997)
Annu. Rev. Biochem.
66,
315-335[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Roquemore, E. P.,
Chou, T. Y.,
and Hart, G. W.
(1994)
Methods Enzymol.
230,
443-460[Medline]
[Order article via Infotrieve]
|
| 3.
|
Thornton, T. M.,
Swain, S. M.,
and Olszewski, N. E.
(1999)
Trends Plant Sci.
4,
424-428[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Wells, L.,
Vosseller, K.,
and Hart, G. W.
(2001)
Science
291,
2376-2378[Abstract/Free Full Text]
|
| 5.
|
Benko, D. M.,
Haltiwanger, R. S.,
Hart, G. W.,
and Gibson, W.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
2573-2577[Abstract/Free Full Text]
|
| 6.
|
Mullis, K. G.,
Haltiwanger, R. S.,
Hart, G. W.,
Marchase, R. B.,
and Engler, J. A.
(1990)
J. Virol.
64,
5317-5323[Abstract/Free Full Text]
|
| 7.
|
Whitford, M.,
and Faulkner, P.
(1992)
J. Virol.
66,
3324-3329[Abstract/Free Full Text]
|
| 8.
|
González, S. A.,
and Burrone, O. R.
(1991)
Virology
182,
8-16[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Revers, F.,
Gall, O. L.,
Candresse, T.,
and Maule, A.
(1999)
Mol. Plant-Microbe Interact.
12,
366-376
|
| 10.
|
Riechmann, J. L.,
Laín, S.,
and García, J. A.
(1992)
J. Gen. Virol.
73,
1-16[Abstract/Free Full Text]
|
| 11.
|
Shukla, D. D.,
Ward, C. W.,
and Brunt, A. A.
(1994)
The Potyviridae
, CAB International, Cambridge
|
| 12.
|
Dolja, V. V.,
Haldeman, R.,
Robertson, N. L.,
Dougherty, W. G.,
and Carrington, J. C.
(1994)
EMBO J.
13,
1482-1491[Medline]
[Order article via Infotrieve]
|
| 13.
|
Dolja, V. V.,
Haldeman-Cahill, R.,
Montgomery, A. E.,
Vandenbosch, K. A.,
and Carrington, J. C.
(1995)
Virology
206,
1007-1016[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Atreya, C. D.,
Raccah, B.,
and Pirone, T. D.
(1990)
Virology
178,
161-165[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Atreya, P. L.,
Atreya, C. D.,
and Pirone, T. P.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7887-7891[Abstract/Free Full Text]
|
| 16.
|
Ivanov, K. I.,
Puustinen, P.,
Merits, A.,
Saarma, M.,
and Makinen, K.
(2001)
J. Biol. Chem.
276,
13530-13540[Abstract/Free Full Text]
|
| 17.
|
López-Moya, J. J.,
Canto, T.,
Díaz-Ruíz, J. R.,
and López-Abella, D.
(1995)
J. Gen. Virol.
76,
2293-2297[Abstract/Free Full Text]
|
| 18.
|
Maiss, E.,
Timpe, U.,
Briske-Rode, A.,
Leseman, D.-E.,
and Casper, R.
(1992)
J. Gen. Virol.
73,
709-713[Abstract/Free Full Text]
|
| 19.
|
Fernández-Fernández, M. R.,
Martínez-Torrecuadrada, J. L.,
Casal, J. I.,
and García, J. A.
(1998)
FEBS Lett.
427,
229-235[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Fernandez-Fernandez, M. R.
(1999)
Use of Plum Pox Virus as an Expression Vector in Plants. Doctoral thesis
, Universidad Autónoma de Madrid
|
| 21.
|
Laín, S.,
Riechmann, J. L.,
Méndez, E.,
and García, J. A.
(1988)
Virus Res.
10,
325-342[CrossRef]
|
| 22.
|
Chaurand, P.,
Luetzenkirchen, F.,
and Spengler, B.
(1999)
J. Am. Soc. Mass Spectrom.
10,
91-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Martín, M. T.,
López-Otín, C.,
Laín, S.,
and García, J. A.
(1990)
Virus Res.
15,
97-106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Comer, F. I.,
and Hart, G. W.
(2000)
J. Biol. Chem.
275,
29179-29182[Free Full Text]
|
| 25.
|
Torres, C. R.,
and Hart, G. W.
(1984)
J. Biol. Chem.
259,
3308-3317[Abstract/Free Full Text]
|
| 26.
|
Heese-Peck, A.,
Cole, R. N.,
Borkhsenious, O. N.,
Hart, G. W.,
and Raikhel, N. V.
(1995)
Plant Cell
7,
1459-1471[Abstract]
|
| 27.
|
Heese-Peck, A.,
and Raikhel, N. V.
(1998)
Plant Cell
10,
599-612[Abstract/Free Full Text]
|
| 28.
|
Roepstorff, P.,
and Folhmann, J.
(1984)
Biomed. Mass Spectrom.
11,
601[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Blom, N.,
Gammeltoft, S.,
and Brunak, S.
(1999)
J. Mol. Biol.
294,
1351-1362[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Shukla, D. D.,
Strike, P. M.,
Tracy, S. L.,
Gough, K. H.,
and Ward, C. W.
(1988)
J. Gen. Virol.
69,
1497-1508
|
| 31.
|
Ratka, M.,
Lackmann, M.,
Ueckermann, C.,
Karlins, U.,
and Koch, G.
(1989)
J. Virol.
63,
3954-3960[Abstract/Free Full Text]
|
| 32.
|
Atabekov, J. G.,
Rodionova, N. P.,
Karpova, O. V.,
Kozlovsky, S. V.,
Novikov, V. K.,
and Arkhipenko, M. V.
(2001)
Virology
286,
466-474[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Karpova, O. V.,
Rodionova, N. P.,
Ivanov, K. I.,
Kozlovsky, S. V.,
Dorokhov, Y. L.,
and Atabekov, J. G.
(1999)
Virology
261,
20-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Partridge, J. E.,
Shannon, L. M.,
Gumpf, D. J.,
and Colbauch, P.
(1974)
Nature
247,
391-392[CrossRef]
|
| 35.
|
Tozzini, A. C., Ek, B.,
Palva, E. T.,
and Hopp, H. E.
(1994)
Virology
202,
651-658[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Altmann, F.,
and Lomonossoff, G. P.
(2000)
J. Gen. Virol.
81,
1111-1114[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. C. Love and J. A. Hanover
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Sci. Signal.,
November 29, 2005;
2005(312):
re13 - re13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chen, S. Juarez, L. Hartweck, J. M. Alamillo, C. Simon-Mateo, J. J. Perez, M. R. Fernandez-Fernandez, N. E. Olszewski, and J. A. Garcia
Identification of Secret Agent as the O-GlcNAc Transferase That Participates in Plum Pox Virus Infection
J. Virol.,
August 1, 2005;
79(15):
9381 - 9387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. I. Ivanov, P. Puustinen, R. Gabrenaite, H. Vihinen, L. Ronnstrand, L. Valmu, N. Kalkkinen, and K. Makinen
Phosphorylation of the Potyvirus Capsid Protein by Protein Kinase CK2 and Its Relevance for Virus Infection
PLANT CELL,
September 1, 2003;
15(9):
2124 - 2139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Puustinen, M.-L. Rajamaki, K. I. Ivanov, J. P. T. Valkonen, and K. Makinen
Detection of the Potyviral Genome-Linked Protein VPg in Virions and Its Phosphorylation by Host Kinases
J. Virol.,
November 13, 2002;
76(24):
12703 - 12711.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|